P
Posos
Biotech & Life Sciences · Paris, France · Founded 2018
Developing artificial intelligence-based solutions, capable of immediately answering questions about medications MoreLess
Posos operates as a global medication data platform, delivering real-time, actionable drug information directly within Electronic Medical Records (EMRs). The company's core technology is centered around artificial intelligence algorithms that are capable of converting free-text, voice, and image-based prescriptions into structured, FHIR-interoperable data. This functionality is designed to streamline the prescription process for healthcare professionals, including doctors and pharmacists, by providing instant analysis of prescriptions against patient data and established medical guidelines.
The platform's database is both multilingual and multi-country, and the medical data is structured using SNOMED, which allows for the integration of additional features such as speech-to-text, predictive health analytics, and dosing suggestions. The business model appears to be B2B, providing its AI-powered services and data to enhance the capabilities of existing EHR systems and other healthcare solutions. By automating and securing the medication prescription and reconciliation circuit, Posos aims to reduce administrative tasks and improve patient safety. The development of the platform has been guided by a scientific committee of medical and pharmaceutical professionals.
Keywords: medication data, prescription analysis, clinical decision support, EHR integration, FHIR, SNOMED, pharmacovigilance, health data, AI in healthcare, drug information
Talent graph
Posos's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Posos's cap table
Sourced from Dealroom's funding and investor records.





Global footprint
Where Posos has talent and traffic
team presence
Market sentiment
What the market is saying about Posos
An AI-synthesized read of the highest-engagement posts about Posos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Posos on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.